bj
Pretty much all the patient-outcome results on here have been reported already, this is just more analysis. The last bit of info was from the C3, where the patient that seemed most promising has reversed trend and is now PD rather than PR. One C3 patient is still SD, but tumor size has increased slightly. Regards analysis, I think the one that most punters will be keen on is - how are the patients? In this case, the answer is not so good. Out of interest, has this increased your confidence in a good outcome for the P2?
Cheers
Ann: Comprehensive Phase Ib HER-Vaxx Results Presented at ESMO, page-14
-
- There are more pages in this discussion • 21 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
4.8¢ |
Change
0.000(0.00%) |
Mkt cap ! $356.9M | |||
| Open | High | Low | Value | Volume |
| 4.9¢ | 4.9¢ | 4.8¢ | $328.5K | 6.792M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 45 | 5443565 | 4.8¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 4.9¢ | 2171910 | 5 |
View Market Depth
| Last trade - 16.10pm 04/10/2024 (20 minute delay) ? |
| IMU (ASX) Chart |